{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:38:27Z","timestamp":1790138307943,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016104","name":"Key Project of Research and Development Plan of Hunan Province","doi-asserted-by":"publisher","award":["CX20251475"],"award-info":[{"award-number":["CX20251475"]}],"id":[{"id":"10.13039\/100016104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014472","name":"Scientific Research Foundation of Hunan Provincial Education Department","doi-asserted-by":"publisher","award":["23A0319"],"award-info":[{"award-number":["23A0319"]}],"id":[{"id":"10.13039\/100014472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30527"],"award-info":[{"award-number":["2023JJ30527"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ6394"],"award-info":[{"award-number":["2024JJ6394"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["S202410555021"],"award-info":[{"award-number":["S202410555021"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118273","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T07:58:11Z","timestamp":1761379091000},"page":"118273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Design of N-salicyltryptamines-based highly selective BChE inhibitors to elevate brain acetylcholine, improve learning, and reduce amyloid-\u03b2 in Alzheimer's disease"],"prefix":"10.1016","volume":"302","author":[{"given":"Kun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4134-1779","authenticated-orcid":false,"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118273_bib1","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.apsb.2022.03.001","article-title":"Mitochondria targeting drugs for neurodegenerative diseases\u2014Design, mechanism and application","volume":"12","author":"Xu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118273_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejmech.2025.118273_bib3","first-page":"6753","article-title":"Neuroinflammation across neurological diseases","volume":"388","author":"Fudong","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118273_bib4","article-title":"The effects of microglia-associated neuroinflammation on Alzheimer's disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118273_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejmech.2025.118273_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101378","article-title":"7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo","volume":"29","author":"Gunesch","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.118273_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejmech.2025.118273_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2019.07.001","article-title":"NSAID-induced corneal melt: clinical importance, pathogenesis, and risk mitigation","volume":"65","author":"Rigas","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejmech.2025.118273_bib9","first-page":"222","article-title":"Design, synthesis and biological evaluation of N-anthraniloyl tryptamine derivatives as pleiotropic molecules for the therapy of malignant glioma","author":"Fan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105255","article-title":"N-salicyloyl tryptamine derivatives as potential therapeutic agents for Alzheimer's disease with neuroprotective effects","volume":"115","author":"Bai","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib11","doi-asserted-by":"crossref","first-page":"28910","DOI":"10.1021\/acsomega.3c04277","article-title":"Exploring the therapeutic effects of multifunctional N-Salicylic acid tryptamine derivative against parkinson's disease","volume":"8","author":"Li","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118273_bib12","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1021\/acschemneuro.3c00149","article-title":"Neuroprotective effects of an N-Salicyloyl tryptamine derivative against cerebral Ischemia\/Reperfusion Injury","volume":"14","author":"Su","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118273_bib13","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/acschemneuro.4c00060","article-title":"N-Salicyloyl tryptamine derivatives as potent neuroinflammation inhibitors by constraining microglia activation via a STAT3 pathway","volume":"15","author":"Zhao","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118273_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116795","article-title":"Design, synthesis and biological evaluation of N-salicyloyl tryptamine derivatives as multifunctional neuroprotectants for the treatment of ischemic stroke","volume":"278","author":"Wu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40035-025-00498-1","article-title":"Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease","volume":"14","author":"Fu","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejmech.2025.118273_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41583-023-00677-x","article-title":"Basal forebrain cholinergic signalling: development, connectivity and roles in cognition","volume":"24","author":"Ananth","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118273_bib17","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1021\/acs.jmedchem.9b00623","article-title":"Dual-acting cholinesterase-human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo","volume":"62","author":"Scheiner","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib18","article-title":"Alzheimer's disease drug development pipeline: 2025","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimer's Dement.: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.ejmech.2025.118273_bib19","article-title":"Alzheimer's disease: molecular aspects and treatment opportunities using herbal drugs. Ageing","volume":"88","author":"Thakral","year":"2023","journal-title":"Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118273_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108748","article-title":"Dual inhibition of butyrylcholinesterase and p38\u03b1 mitogen-activated protein kinase: a new approach for the treatment of Alzheimer's disease","volume":"264","author":"Ferjancic Benetik","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.118273_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14814","article-title":"The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease","volume":"30","author":"Carles","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2025.118273_bib22","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1021\/acs.jmedchem.2c00944","article-title":"N-Benzyl benzamide derivatives as selective sub-nanomolar butyrylcholinesterase inhibitors for possible treatment in advanced Alzheimer's disease","volume":"65","author":"Du","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103310","article-title":"Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors","volume":"93","author":"Mo","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib24","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.apsb.2025.02.030","article-title":"Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease","volume":"15","author":"Sang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118273_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/cn500016p","article-title":"Acetylcholinesterase inhibitors with photoswitchable inhibition of beta-amyloid aggregation","volume":"5","author":"Chen","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118273_bib26","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1021\/acs.jmedchem.4c00355","article-title":"Butyrylcholinesterase-activated near-infrared fluorogenic probe for in vivo theranostics of Alzheimer's disease","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib27","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1021\/acs.jmedchem.3c00541","article-title":"Dual-acting small molecules: subtype-selective cannabinoid receptor 2 agonist\/butyrylcholinesterase inhibitor hybrids show neuroprotection in an Alzheimer's disease mouse model","volume":"66","author":"Spatz","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","article-title":"Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease","volume":"132","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105993","article-title":"Discovery of carbamate-based N-salicyloyl tryptamine derivatives as novel pleiotropic agents for the treatment of Alzheimer's disease","volume":"127","author":"Wang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114044","article-title":"Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103844","article-title":"Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer's disease","volume":"99","author":"Liao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib32","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/cmdc.201500418","article-title":"Aminobenzimidazoles and structural isomers as templates for dual-acting butyrylcholinesterase inhibitors and hCB2R ligands to combat neurodegenerative disorders","volume":"11","author":"Dolles","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118273_bib33","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jmedchem.5b01674","article-title":"Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode","volume":"59","author":"Sawatzky","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2014.05.002","article-title":"Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine","volume":"81","author":"Huang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114729","article-title":"Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"243","author":"Lu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115910","article-title":"Drug and pro-drug substrates and pseudo-substrates of human butyrylcholinesterase","volume":"218","author":"Masson","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118273_bib37","first-page":"858","article-title":"Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer's disease, and fat metabolism","volume":"21","author":"Xing","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118273_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115044","article-title":"Luteolin binds Src, promotes STAT3 protein ubiquitination and exerts anti-melanoma effects in cell and mouse models","volume":"200","author":"Li","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118273_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-024-02790-2","article-title":"Inflammatory aspects of Alzheimer's disease","volume":"148","author":"Botella Lucena","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2025.118273_bib40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4103\/1673-5374.295339","article-title":"Co-nanoencapsulated meloxicam and curcumin improves cognitive impairment induced by amyloid-beta through modulation of cyclooxygenase-2 in mice","volume":"16","author":"Gutierrez","year":"2021","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.ejmech.2025.118273_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115491","article-title":"LiuweiDihuang improved cognitive functions in SAMP8 mice by inhibiting COX-2 expression and subsequent neuroinflammation","volume":"296","author":"Song","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2025.118273_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107931","article-title":"Indole-based COX-2 inhibitors: a decade of advances in inflammation, cancer, and Alzheimer's therapy","volume":"153","author":"Shah","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib43","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/med.21947","article-title":"Regulation of beta-amyloid for the treatment of Alzheimer's disease: research progress of therapeutic strategies and bioactive compounds","volume":"43","author":"Qiu","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118273_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106056","article-title":"Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates","volume":"168","author":"Radan","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2025.118273_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2014.12.014","article-title":"Prediction of blood\u2013brain barrier permeation of \u03b1-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis","volume":"68","author":"Vucicevic","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2025.118273_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Kosak","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118273_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.phrs.2010.02.009","article-title":"Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review","volume":"61","author":"Repantis","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118273_bib48","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.apsb.2025.01.015","article-title":"Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease","volume":"15","author":"Wei","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118273_bib49","doi-asserted-by":"crossref","first-page":"10030","DOI":"10.1021\/acs.jmedchem.0c01129","article-title":"Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib50","article-title":"New insights into butyrylcholinesterase: pharmaceutical applications, selective inhibitors and multitarget-directed ligands","volume":"275","author":"Tianyu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116463","article-title":"Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease","volume":"272","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib52","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ejmech.2025.118273_bib53","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1039\/D2MD00087C","article-title":"Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse model","volume":"13","author":"Zimmermann","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib54","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/D4MD00617H","article-title":"Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity","volume":"16","author":"Buza","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118273_bib55","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1021\/acs.chemrestox.9b00168","article-title":"Multifunctional Mono-Triazole derivatives inhibit Abeta(42) aggregation and Cu(2+)-Mediated Abeta(42) aggregation and protect against Abeta(42)-Induced cytotoxicity","volume":"32","author":"Kaur","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2025.118273_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejps.2015.08.019","article-title":"Tuning the predictive capacity of the PAMPA-BBB model","volume":"79","author":"Muller","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2025.118273_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:58:02Z","timestamp":1773269882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":57,"alternative-id":["S0223523425010384"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118273","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of N-salicyltryptamines-based highly selective BChE inhibitors to elevate brain acetylcholine, improve learning, and reduce amyloid-\u03b2 in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118273"}}